US Stock MarketDetailed Quotes

TRVI Trevi Therapeutics

Watchlist

2.840
-0.060-2.07%

Trading Jul 17 15:38 ET

200.04MMarket Cap-8352P/E (TTM)

Trevi Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

Total revenue

Operating revenue

--0

Cost of revenue

Gross profit

Operating expense

57.42%11.91M

13.43%33.92M

34.19%8.93M

7.61%9.05M

7.19%8.38M

7.66%7.56M

-7.91%29.91M

-19.53%6.66M

20.99%8.41M

-14.69%7.82M

Selling and administrative expenses

21.03%3.1M

1.66%10.24M

3.21%2.42M

3.26%2.72M

-6.51%2.54M

7.69%2.56M

6.12%10.07M

11.75%2.34M

18.26%2.64M

1.80%2.72M

-General and administrative expense

21.03%3.1M

1.66%10.24M

3.21%2.42M

3.26%2.72M

-6.51%2.54M

7.69%2.56M

6.12%10.07M

11.75%2.34M

18.26%2.64M

1.80%2.72M

Research and development costs

76.08%8.8M

19.41%23.68M

50.98%6.52M

9.60%6.32M

14.48%5.84M

7.64%5M

-13.71%19.83M

-30.13%4.32M

22.28%5.77M

-21.47%5.1M

Operating profit

-57.42%-11.91M

-13.43%-33.92M

-34.19%-8.93M

-7.61%-9.05M

-7.19%-8.38M

-7.66%-7.56M

7.91%-29.91M

19.53%-6.66M

-20.99%-8.41M

14.69%-7.82M

Net non-operating interest income expense

0.71%997K

655.11%4.36M

34.40%1.13M

793.94%1.18M

1,156.00%1.06M

432.21%990K

148.41%577K

375.49%843K

143.85%132K

65.99%-100K

Non-operating interest income

-18.26%998K

172.87%4.75M

1.79%1.14M

179.01%1.18M

518.97%1.21M

30,425.00%1.22M

17,300.00%1.74M

37,133.33%1.12M

21,100.00%424K

9,650.00%195K

Non-operating interest expense

-99.57%1K

-66.38%391K

-98.54%4K

-98.97%3K

-48.81%151K

-23.51%231K

-3.24%1.16M

-11.33%274K

-3.63%292K

-0.34%295K

Other net income (expense)

-100.61%-1K

230.28%469K

-101.04%-3K

154K

212.50%153K

1,600.00%165K

148.46%142K

445.28%289K

59.40%-136K

Gain on sale of security

----

-279.27%-147K

--0

----

-440.00%-136K

Other non- operating income (expenses)

-100.61%-1K

62.28%469K

---3K

--154K

--153K

--165K

177.07%289K

----

Income before tax

-70.26%-10.91M

0.31%-29.1M

-41.23%-7.8M

6.79%-7.71M

10.94%-7.18M

12.63%-6.41M

14.05%-29.19M

35.20%-5.53M

-14.06%-8.27M

17.76%-8.06M

Income tax

-14.29%-8K

11.11%-32K

190.00%18K

-85.71%-13K

-650.00%-30K

-40.00%-7K

-71.43%-36K

-233.33%-20K

-450.00%-7K

-100.00%-4K

Net income

-70.32%-10.9M

0.30%-29.07M

-42.07%-7.82M

6.87%-7.7M

11.26%-7.15M

12.66%-6.4M

14.11%-29.15M

35.39%-5.51M

-13.94%-8.27M

17.79%-8.05M

Net income continuous Operations

-70.32%-10.9M

0.30%-29.07M

-42.07%-7.82M

6.87%-7.7M

11.26%-7.15M

12.66%-6.4M

14.11%-29.15M

35.39%-5.51M

-13.94%-8.27M

17.79%-8.05M

Minority interest income

Net income attributable to the parent company

-70.32%-10.9M

0.30%-29.07M

-42.07%-7.82M

6.87%-7.7M

11.26%-7.15M

12.66%-6.4M

14.11%-29.15M

35.39%-5.51M

-13.94%-8.27M

17.79%-8.05M

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

-70.32%-10.9M

0.30%-29.07M

-42.07%-7.82M

6.87%-7.7M

11.26%-7.15M

12.66%-6.4M

14.11%-29.15M

35.39%-5.51M

-13.94%-8.27M

17.79%-8.05M

Basic earnings per share

-83.33%-0.11

35.56%-0.29

-33.33%-0.08

33.33%-0.08

50.00%-0.07

75.00%-0.06

69.80%-0.45

75.00%-0.06

64.71%-0.12

71.43%-0.14

Diluted earnings per share

-83.33%-0.11

35.56%-0.29

-33.33%-0.08

33.33%-0.08

50.00%-0.07

75.00%-0.06

69.80%-0.45

75.00%-0.06

64.71%-0.12

71.43%-0.14

Dividend per share

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022
Total revenue	0	0	0	0	0	0	0	0	0	0
Operating revenue	--0	--0	--0	--0	--0	--0	--0	--0	--0	--0
Cost of revenue
Gross profit
Operating expense	57.42%11.91M	13.43%33.92M	34.19%8.93M	7.61%9.05M	7.19%8.38M	7.66%7.56M	-7.91%29.91M	-19.53%6.66M	20.99%8.41M	-14.69%7.82M
Selling and administrative expenses	21.03%3.1M	1.66%10.24M	3.21%2.42M	3.26%2.72M	-6.51%2.54M	7.69%2.56M	6.12%10.07M	11.75%2.34M	18.26%2.64M	1.80%2.72M
-General and administrative expense	21.03%3.1M	1.66%10.24M	3.21%2.42M	3.26%2.72M	-6.51%2.54M	7.69%2.56M	6.12%10.07M	11.75%2.34M	18.26%2.64M	1.80%2.72M
Research and development costs	76.08%8.8M	19.41%23.68M	50.98%6.52M	9.60%6.32M	14.48%5.84M	7.64%5M	-13.71%19.83M	-30.13%4.32M	22.28%5.77M	-21.47%5.1M
Operating profit	-57.42%-11.91M	-13.43%-33.92M	-34.19%-8.93M	-7.61%-9.05M	-7.19%-8.38M	-7.66%-7.56M	7.91%-29.91M	19.53%-6.66M	-20.99%-8.41M	14.69%-7.82M
Net non-operating interest income expense	0.71%997K	655.11%4.36M	34.40%1.13M	793.94%1.18M	1,156.00%1.06M	432.21%990K	148.41%577K	375.49%843K	143.85%132K	65.99%-100K
Non-operating interest income	-18.26%998K	172.87%4.75M	1.79%1.14M	179.01%1.18M	518.97%1.21M	30,425.00%1.22M	17,300.00%1.74M	37,133.33%1.12M	21,100.00%424K	9,650.00%195K
Non-operating interest expense	-99.57%1K	-66.38%391K	-98.54%4K	-98.97%3K	-48.81%151K	-23.51%231K	-3.24%1.16M	-11.33%274K	-3.63%292K	-0.34%295K
Other net income (expense)	-100.61%-1K	230.28%469K	-101.04%-3K	154K	212.50%153K	1,600.00%165K	148.46%142K	445.28%289K		59.40%-136K
Gain on sale of security	----	----	----	----	----	----	-279.27%-147K	--0	----	-440.00%-136K
Other non- operating income (expenses)	-100.61%-1K	62.28%469K	---3K	--154K	--153K	--165K	177.07%289K	----	----	----
Income before tax	-70.26%-10.91M	0.31%-29.1M	-41.23%-7.8M	6.79%-7.71M	10.94%-7.18M	12.63%-6.41M	14.05%-29.19M	35.20%-5.53M	-14.06%-8.27M	17.76%-8.06M
Income tax	-14.29%-8K	11.11%-32K	190.00%18K	-85.71%-13K	-650.00%-30K	-40.00%-7K	-71.43%-36K	-233.33%-20K	-450.00%-7K	-100.00%-4K
Net income	-70.32%-10.9M	0.30%-29.07M	-42.07%-7.82M	6.87%-7.7M	11.26%-7.15M	12.66%-6.4M	14.11%-29.15M	35.39%-5.51M	-13.94%-8.27M	17.79%-8.05M
Net income continuous Operations	-70.32%-10.9M	0.30%-29.07M	-42.07%-7.82M	6.87%-7.7M	11.26%-7.15M	12.66%-6.4M	14.11%-29.15M	35.39%-5.51M	-13.94%-8.27M	17.79%-8.05M
Minority interest income
Net income attributable to the parent company	-70.32%-10.9M	0.30%-29.07M	-42.07%-7.82M	6.87%-7.7M	11.26%-7.15M	12.66%-6.4M	14.11%-29.15M	35.39%-5.51M	-13.94%-8.27M	17.79%-8.05M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders	-70.32%-10.9M	0.30%-29.07M	-42.07%-7.82M	6.87%-7.7M	11.26%-7.15M	12.66%-6.4M	14.11%-29.15M	35.39%-5.51M	-13.94%-8.27M	17.79%-8.05M
Basic earnings per share	-83.33%-0.11	35.56%-0.29	-33.33%-0.08	33.33%-0.08	50.00%-0.07	75.00%-0.06	69.80%-0.45	75.00%-0.06	64.71%-0.12	71.43%-0.14
Diluted earnings per share	-83.33%-0.11	35.56%-0.29	-33.33%-0.08	33.33%-0.08	50.00%-0.07	75.00%-0.06	69.80%-0.45	75.00%-0.06	64.71%-0.12	71.43%-0.14
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	Unqualified Opinion	--	--	--	--	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall